Figure 5.

Model-predicted cure rates after different treatment durations for the 3 treatment regimens, using 1000 bootstraps of the original data set and with reestimation using the final model. The lines resemble mean probabilities of cure, and gray-shaded areas, 90% confidence intervals of the predictions from the 1000 distributions of the reestimated model parameters. Abbreviations: BPaL, bedaquiline and pretomanid combined with linezolid; BPaMZ, bedaquiline and pretomanid combined with moxifloxacin and pyrazinamide; HRZE, isoniazid, rifampicin, pyrazinamide, and ethambutol.